Fig. 1 (Abstract A9).
Percentage of JIA Patients receiving Biologic DMARDs in the respective year and dates of first approval in Europe (2000–2024)
Fig. 1 (Abstract A9). | Pediatric Rheumatology
Percentage of JIA Patients receiving Biologic DMARDs in the respective year and dates of first approval in Europe (2000–2024)
Pediatric Rheumatology